Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series B
Biotech
Neuropsych biotech Engrail closes $157M series B
Engrail CEO Vikram Sudarsan said the new cash extends the company's runway into the middle of 2026.
Max Bayer
Mar 19, 2024 8:00am
Tubulis rides wave of ADC interest to $138M financing round
Mar 14, 2024 9:12am
Sionna adds $182M to extend pipeline, cash runway through 2026
Mar 6, 2024 8:00am
Capitalizing on ADC frenzy, ProfoundBio attracts $112M series B
Feb 13, 2024 7:00am
Ambience Healthcare reels in $70M for generative AI tools
Feb 7, 2024 10:18am
Sanofi-backed Sudo seals $116M series B
Dec 20, 2023 8:30am